Long-term immunological consequences of anti-CD20 therapies on humoral responses to COVID-19 vaccines in multiple sclerosis: an observational study

BACKGROUND: Anti-CD20 therapies induce pronounced B-cell depletion and blunt humoral responses to vaccines. Recovery kinetics of anti-CD20 therapy-mediated cellular and humoral effects in people with multiple sclerosis (pwMS) are poorly defined. OBJECTIVE: To investigate the duration of the anti-CD2...

Descripción completa

Detalles Bibliográficos
Autores principales: Moser, Tobias, O’Sullivan, Ciara, Otto, Ferdinand, Hitzl, Wolfgang, Pilz, Georg, Schwenker, Kerstin, Mrazek, Cornelia, Haschke-Becher, Elisabeth, Trinka, Eugen, Wipfler, Peter, Harrer, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Neurology in the Time of COVID-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036387/
https://www.ncbi.nlm.nih.gov/pubmed/35479655
http://dx.doi.org/10.1177/17562864221092092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036387/
https://www.ncbi.nlm.nih.gov/pubmed/35479655
http://dx.doi.org/10.1177/17562864221092092

Ejemplares similares